These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23168914)

  • 1. Effects of citalopram on serotonin neurotransmission.
    Selvaraj S; Faulkner P; Mouchlianitis E; Roiser JP; Howes O
    Mol Psychiatry; 2012 Dec; 17(12):1143. PubMed ID: 23168914
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression and impact of Lsamp neural adhesion molecule in the serotonergic neurotransmission system.
    Bregin A; Kaare M; Jagomäe T; Karis K; Singh K; Laugus K; Innos J; Leidmaa E; Heinla I; Visnapuu T; Oja EM; Kõiv K; Lilleväli K; Harro J; Philips MA; Vasar E
    Pharmacol Biochem Behav; 2020 Nov; 198():173017. PubMed ID: 32828972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
    Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
    Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo.
    Miguelez C; Navailles S; Delaville C; Marquis L; Lagière M; Benazzouz A; Ugedo L; De Deurwaerdère P
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1297-309. PubMed ID: 27234917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.
    Millan MJ; Gobert A; Rivet JM; Adhumeau-Auclair A; Cussac D; Newman-Tancredi A; Dekeyne A; Nicolas JP; Lejeune F
    Eur J Neurosci; 2000 Mar; 12(3):1079-95. PubMed ID: 10762339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple reuptake inhibition of serotonin, norepinephrine, and dopamine increases the tonic activation of α
    Jiang JL; El Mansari M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109987. PubMed ID: 32474007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring endogenous changes in serotonergic neurotransmission with [
    da Cunha-Bang S; Ettrup A; Mc Mahon B; Skibsted AP; Schain M; Lehel S; Dyssegaard A; Jørgensen LM; Møller K; Gillings N; Svarer C; Knudsen GM
    Transl Psychiatry; 2019 Apr; 9(1):134. PubMed ID: 30975977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmenting serotonin neurotransmission with citalopram modulates emotional expression decoding but not structural encoding of moderate intensity sad facial emotional stimuli: an event-related potential (ERP) investigation.
    Labuschagne I; Croft RJ; Phan KL; Nathan PJ
    J Psychopharmacol; 2010 Aug; 24(8):1153-64. PubMed ID: 18832432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats.
    Nguyen KQ; Tohyama Y; Watanabe A; Hasegawa S; Skelin I; Diksic M
    Neurochem Int; 2009; 54(3-4):161-71. PubMed ID: 19073228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Playing it safe but losing anyway--serotonergic signaling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversion.
    Macoveanu J; Rowe JB; Hornboll B; Elliott R; Paulson OB; Knudsen GM; Siebner HR
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):919-30. PubMed ID: 23051938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.
    Asaoka N; Nagayasu K; Nishitani N; Yamashiro M; Shirakawa H; Nakagawa T; Kaneko S
    Neuropharmacology; 2015 Aug; 95():261-8. PubMed ID: 25863120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline.
    Guille V; Croft RJ; O'Neill BV; Illic S; Phan KL; Nathan PJ
    Hum Psychopharmacol; 2008 Apr; 23(3):231-41. PubMed ID: 18196604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.
    Teixeira-Castro A; Jalles A; Esteves S; Kang S; da Silva Santos L; Silva-Fernandes A; Neto MF; Brielmann RM; Bessa C; Duarte-Silva S; Miranda A; Oliveira S; Neves-Carvalho A; Bessa J; Summavielle T; Silverman RB; Oliveira P; Morimoto RI; Maciel P
    Brain; 2015 Nov; 138(Pt 11):3221-37. PubMed ID: 26373603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram.
    Arborelius L; Nomikos GG; Grillner P; Hertel P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):157-65. PubMed ID: 7477438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antidepressant fluoxetine but not citalopram suppresses synapse formation and synaptic transmission between Lymnaea neurons by perturbing presynaptic and postsynaptic machinery.
    Getz A; Xu F; Zaidi W; Syed NI
    Eur J Neurosci; 2011 Jul; 34(2):221-34. PubMed ID: 21722207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study.
    Selvaraj S; Turkheimer F; Rosso L; Faulkner P; Mouchlianitis E; Roiser JP; McGuire P; Cowen PJ; Howes O
    Mol Psychiatry; 2012 Dec; 17(12):1254-60. PubMed ID: 22665264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal fluoxetine exposure modulates serotonergic neurotransmission and disturb inhibitory action of serotonin on food intake.
    Pinheiro IL; da Silva AI; Reginato A; da Silva Filho RC; Galindo LCM; Matos RJB; de Souza Ferraz JC; Toscano Meneses da Silva Castro AE; Milanski Ferreira M; Manhães de Castro R; de Souza SL
    Behav Brain Res; 2019 Jan; 357-358():65-70. PubMed ID: 28756214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 and selective 5-HT1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in conditioned fear stress in the rat.
    Muraki I; Inoue T; Koyama T
    Eur J Pharmacol; 2008 May; 586(1-3):171-8. PubMed ID: 18423441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram.
    Kuan WL; Zhao JW; Barker RA
    Psychopharmacology (Berl); 2008 Apr; 197(2):279-93. PubMed ID: 18157704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
    Guiard BP; Mansari ME; Murphy DL; Blier P
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.